ANIPANI Pharmaceuticals, Inc.
82.77USDMkt Cap: 1.88B USDP/E: 20.95Last update: 2026-05-21

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel …

loading…
Indicators:|

Key Statistics

Company
Market Cap1.88B USD
Enterprise Value2.06B USD
Revenue (TTM)923.71M USD
Gross Profit542.06M USD
Net Income (TTM)78.34M USD
Revenue/Share45.33 USD
Last Price82.77 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees970
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS00182C1036
Valuation
P/E (Trailing)20.95
P/E (Forward)7.80
PEG
EV/EBITDA10.43
EV/Revenue2.23
P/S2.04
P/B3.14
EPS (TTM)3.91
EPS (Forward)10.61
52W Range
80.7383% of range83.19
52W High83.19 USD
52W Low80.73 USD
Profitability
Gross Margin61.36%
Oper. Margin16.30%
EBITDA Margin21.37%
Profit Margin8.87%
ROE14.49%
ROA5.44%
Growth
Revenue Growth20.50%
Earnings Growth86.10%
Cash Flow & Leverage
Operating CF185.22M USD
CapEx (TTM)34.32M USD
FCF Margin15.18%
FCF Yield7.45%
Net Debt304.15M USD
Net Debt/EBITDA1.54
Balance Sheet
Debt/Equity1.14
Current Ratio3.12
Quick Ratio2.43
Book Value/Sh26.34 USD
Cash/Share15.38 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:6
Split DateJul 18, 2013
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)109.88 USD
Target Range90.00 USD124.00 USD
# Analysts8
Ownership
Shares Out.22.73M
Float19.46M
Insiders6.89%
Institutions110.30%
Short Interest
Short Ratio10.8d
Short % Float18.98%
Short % Out.15.57%
Shares Short3.56M
Short (prev mo.)3.58M
Technical
SMA 5078.01 (+6.1%)
SMA 20083.77 (-1.2%)
Beta0.46
S&P 52W Chg28.31%
Avg Vol (30d)236.37K
Avg Vol (10d)471.94K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)